Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Storify: Pathways to Access #GSIPA2M
[View the story “Pathways to Access! #GSIPA2M (15-17 Jan 2018)” on Storify] SaveSave
GSIPA2M: The Summit Highlights
Catch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....
IP and access to medicines: welcome speech
Our inaugural Global Summit on Intellectual Property and Access to Medicines has started today. Read Solange Baptiste’s welcoming speech below,...
ICASA 2017: Optimal HIV treatment for ALL
As the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
BLOG: 29 developing countries excluded from optimal HIV treatment – a dangerous oversight or deliberate tactic?
This World AIDS Day (1 December 2017), we’re pleased to have reached a point where more people are set to...
‘Questionable’ patent on key HIV drug is challenged in Brazil
Legal challenge essential to prevent further barriers to optimal HIV treatment in Brazil. ABIA, our campaign partner in Brazil, is...
São Paulo protest exposes how Gilead’s actions block access to medicines around the world
In São Paulo, on 31 October 2017, activists from around the world held a protest at the headquarters of...
New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...
The Indonesian patent club – and its impact on Hep C treatment
Communities are refusing to accept patent abuse – challenging unmerited patents, and finding ways around them in the meantime. Community...